Paper39796183
Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness.
Gambacurta A and 5 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness. Papers, record 39796183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39796183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Breast Neoplasms | Major topic |
| Kruppel-Like Transcription Factors | Major topic |
| Trans-Activators | Major topic |
| Carcinogenesis | Major topic |
| Neoplastic Stem Cells | Major topic |
| Humans | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Proto-Oncogene Mas | |
| Cell Line, Tumor | |
| Proto-Oncogene Protein c-ets-2 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2007KAWXCL_002 | Italian Ministry of Research | PubMed | ||
| 0000147/2022 | Tor Vergata University of Rome | PubMed | ||
| Progetto cellule staminali | NAST Centre | PubMed | ||
| PNC-E3-2022-23683266 PNCHLS-DA project | Diagnostica Avanzata | PubMed |
Source PubMed
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32410348 | miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32410348 | PubMed |
| 2 | 20708002 | Dysregulation of microRNAs in cancer: playing with fire. | FEBS Lett | 2011 | https://conductscience.org/library/papers/20708002 | PubMed |
| 3 | 32858223 | hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. | Genomics Proteomics Bioinformatics | 2020 | https://conductscience.org/library/papers/32858223 | PubMed |
| 4 | 24368110 | miR-126 in human cancers: clinical roles and current perspectives. | Exp Mol Pathol | 2014 | https://conductscience.org/library/papers/24368110 | PubMed |
| 5 | 24996968 | The clinicopathological significance of neurogenesis in breast cancer. | BMC Cancer | 2014 | https://conductscience.org/library/papers/24996968 | PubMed |
| 6 | 29778234 | EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer. | Cancer Genet | 2018 | https://conductscience.org/library/papers/29778234 | PubMed |
| 7 | 29327503 | Noncoding RNAs in Alzheimer's disease. | Wiley Interdiscip Rev RNA | 2018 | https://conductscience.org/library/papers/29327503 | PubMed |
| 8 | 23900443 | Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. | Oncol Rep | 2013 | https://conductscience.org/library/papers/23900443 | PubMed |
| 9 | 19116145 | Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19116145 | PubMed |
| 10 | 23102669 | MicroRNA and cancer. | Mol Oncol | 2012 | https://conductscience.org/library/papers/23102669 | PubMed |
| 11 | 31665654 | Polyunsaturated fatty acids modulate the delivery of platelet microvesicle-derived microRNAs into human breast cancer cell lines. | J Nutr Biochem | 2019 | https://conductscience.org/library/papers/31665654 | PubMed |
| 12 | 32424275 | Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. | Nat Cell Biol | 2020 | https://conductscience.org/library/papers/32424275 | PubMed |
| 13 | 26463235 | Methylation of the miR-126 gene associated with glioma progression. | Fam Cancer | 2016 | https://conductscience.org/library/papers/26463235 | PubMed |
| 14 | 35328298 | miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35328298 | PubMed |
| 15 | 33468253 | Neural stemness contributes to cell tumorigenicity. | Cell Biosci | 2021 | https://conductscience.org/library/papers/33468253 | PubMed |
| 16 | 19493678 | Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19493678 | PubMed |
| 17 | 20619534 | miR-126 functions as a tumour suppressor in human gastric cancer. | Cancer Lett | 2010 | https://conductscience.org/library/papers/20619534 | PubMed |
| 18 | 19047084 | Cancer-related axonogenesis and neurogenesis in prostate cancer. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/19047084 | PubMed |
| 19 | 36091786 | Emerging role of different DNA methyltransferases in the pathogenesis of cancer. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36091786 | PubMed |
| 20 | 20671229 | Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. | Arterioscler Thromb Vasc Biol | 2010 | https://conductscience.org/library/papers/20671229 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41154638 | Bioinformatics Strategies in Breast Cancer Research. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154638 | PubMed |
| 41011238 | The Role of Non-Coding Regions in Breast Cancer: From Gene Regulation to Therapeutic Implications. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011238 | PubMed |
| 40149447 | The Emerging Role of MicroRNAs in Nasal Inflammatory Diseases and Tumors: From Bench to Bedside. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40149447 | PubMed |
| 40141248 | Decoding the Epigenome of Breast Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141248 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| EBF1 | 1879 | PubTator's text mining | https://conductscience.org/library/genes/1879 | NCBI Gene |
| ETS2 | 2114 | PubTator's text mining | https://conductscience.org/library/genes/2114 | NCBI Gene |
| KLF2 | 10365 | PubTator's text mining | https://conductscience.org/library/genes/10365 | NCBI Gene |
| MIR126 | 406913 | PubTator's text mining | https://conductscience.org/library/genes/406913 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39796183
GET https://conductscience.org/api/papers/v1/39796183/references?page=2